Hosted in the Lloyd’s Lab, the LMA event will be joined by Libbe. L. Englander, CEO and founder of Pharm3r, a healthcare analytics company which specialises in using real-world data for the post-market surveillance of drugs, devices and manufacturing facilities.

The event will cover the following major topics of discussion:

• how new technology could assist in Prospecting, Risk selection, Aggregation Exposure Tracking and Pricing
• what is the process and cost of recall? Looking at the frequency of recalls over the years
• what is the regulatory environment on emergent product liability and supply chain/recall risks?
• what data analytic technologies could we be harnessing to augment the underwriting decision making process?